Paper8575795
Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
Kashmiri SV and 5 others. Hybridoma, 1995. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49. Papers, record 8575795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8575795
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antibodies, Neoplasm | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Antigens, Neoplasm | |
| Base Sequence | |
| Binding, Competitive | |
| Female | |
| Genes, Immunoglobulin | |
| Genetic Vectors | |
| Glycoproteins | |
| Humans | |
| Immunoglobulin Heavy Chains | |
| Immunoglobulin Light Chains | |
| Immunoglobulin Variable Region | |
| Mice | |
| Mice, Nude | |
| Molecular Sequence Data | |
| Radioimmunoassay | |
| Recombinant Fusion Proteins | |
| Tumor Cells, Cultured |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40925376 | Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40925376 | PubMed |
| 37509200 | Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37509200 | PubMed |
| 35158915 | Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158915 | PubMed |
| 33614914 | Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer. | Mol Ther Oncolytics | 2021 | https://conductscience.org/library/papers/33614914 | PubMed |
| 32217350 | Humanized Anti-Tumor-Associated Glycoprotein-72 for Submillimeter Near-Infrared Detection of Colon Cancer in Metastatic Mouse Models. | J Surg Res | 2020 | https://conductscience.org/library/papers/32217350 | PubMed |
| 30510550 | Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells. | Front Immunol | 2018 | https://conductscience.org/library/papers/30510550 | PubMed |
| 30052649 | Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma. | PLoS One | 2018 | https://conductscience.org/library/papers/30052649 | PubMed |
| 28344808 | Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer. | J Immunother Cancer | 2017 | https://conductscience.org/library/papers/28344808 | PubMed |
| 23015323 | Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen. | Mol Biotechnol | 2013 | https://conductscience.org/library/papers/23015323 | PubMed |
| 20980835 | Identification of a high affinity TAG-72 binding peptide by phage display selection. | Cancer Biol Ther | 2011 | https://conductscience.org/library/papers/20980835 | PubMed |
| 19173715 | A comprehensive overview of radioguided surgery using gamma detection probe technology. | World J Surg Oncol | 2009 | https://conductscience.org/library/papers/19173715 | PubMed |
| 19019238 | Gamma probes and their use in tumor detection in colorectal cancer. | Int Semin Surg Oncol | 2008 | https://conductscience.org/library/papers/19019238 | PubMed |
| 18309354 | Targeted gene therapy of LS174 T human colon carcinoma by anti-TAG-72 immunoliposomes. | Cancer Gene Ther | 2008 | https://conductscience.org/library/papers/18309354 | PubMed |
| 17034135 | Enzyme specific activation of benzoquinone ansamycin prodrugs using HuCC49DeltaCH2-beta-galactosidase conjugates. | J Med Chem | 2006 | https://conductscience.org/library/papers/17034135 | PubMed |
| 15846298 | HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo. | Br J Cancer | 2005 | https://conductscience.org/library/papers/15846298 | PubMed |
| 10596374 | Generation of recombinant antibodies. | Mol Biotechnol | 1999 | https://conductscience.org/library/papers/10596374 | PubMed |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8575795
GET https://conductscience.org/api/papers/v1/8575795/authors